• Pharma
  • March 26, 2021
Dr Reddy’s submits Indian trials data of Sputnik to DCGI

Hyderabad: Dr Reddy’s Laboratories, which has applied for emergency use authorisation (EUA) for Russian C-19 vaccine Sputnik V, has submitted data from the Indian Phase II/III trials as directed by the expert committee that…

  • Pharma
  • January 4, 2021
Submitted All Data As Per Guidelines, Says Bharat Biotech

HYDERABAD : Amid concerns over the Indian drug regulator granting emergency use authorisation (EUA) approval to the indigenous Covid-19 vaccine candidate Covaxin even as its Phase 3 trials are underway,…

  • Pharma
  • January 1, 2021
India will have happy New Year with vaccine in hand: DCGI

The drug regulator is currently analysing the data submitted by Serum Institute of India, which is manufacturing Oxford-AstraZeneca vaccine and Bharat Biotech, which is making indigenous vaccine in collaboration with ICMR. The expert panel…